Hiroyuki Nodera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiroyuki Nodera has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Ryuji Kaji
Center for Research Administration and Collaboration, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
17 shared publicationsAtsuko Mori
Department of Neurology Tokushima University Tokushima Japan
13 shared publicationsYoshimitsu Shimatani
From the Faculty of Medicine (K.S.) and Department of Neurology (H.N., N.T., A.M., H.Y., Y.S., Y.I., R.K.), Tokushima University, 3-18-15 Kuramotocho, Tokushima 770-8503, Japan; and Department of Neurology, Vihara Hananosato Hospital, Hiroshima, Japan (N.T., Y.I.).
11 shared publicationsNaoko Takamatsu
10 shared publicationsYuishin Izumi
Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
10 shared publicationsYusuke Osaki
Department of Neurology Tokushima University Tokushima Japan
9 shared publications
Latest Publications
- Open Access
- 15 May 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 175
Evaluation of the diagnostic performance of brachial plexus ultrasound in amyotrophic lateral sclerosis
- 15 May 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 175
Open AccessEvaluation of the diagnostic performance of brachial plexus ultrasound in amyotrophic lateral sclerosis
- 13 December 2024
- Published by Elsevier in Clinical Neurophysiology
- Vol. 170, 156-167
Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis
- 13 December 2024
- Published by Elsevier in Clinical Neurophysiology
- Vol. 170, 156-167
Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis
- 22 April 2023
- Published by Wiley in Muscle & Nerve
- Vol. 68 (3) , 257-263
Far‐field potential of the compound muscle action potential as a reliable marker in amyotrophic lateral sclerosis
Introduction/AimsReliable neurophysiological markers in amyotrophic lateral sclerosis (ALS) are of great interest. The compound muscle action potential (CMAP) amplitude has been a conventional marker, although it is greatly influenced by the electrode position. We propose the far-field potential of the CMAP (FFP-CMAP) as a new neurophysiological marker in ALS. MethodsPatients with ALS and age-matched healthy controls were enrolled. We used a proximal reference (pref) in addition to the conventional distal reference (dref). Routine CMAP was recorded from the belly-dref lead and FFP-CMAP from the dref-pref lead for the ulnar and tibial nerves. Multiple point stimulation motor unit number estimation (MUNE) was also examined in the ulnar nerve. Inter-rater reproducibility was evaluated by two examiners, and some patients were followed up every 3 mo for 1 y. ResultsWe tested 17 patients with ALS and 10 controls. The amplitudes of routine CMAP and FFP-CMAP in the ulnar and tibial nerves, and hypothenar MUNE value in the ulnar nerve were significantly decreased in ALS compared to controls. Ulnar FFP-CMAP achieved the highest inter-rater intraclass correlation coefficient (ICC) value (0.942) when compared with routine CMAP (0.880) and MUNE (0.839). The tibial FFP-CMAP had a higher ICC value (0.986) than the routine CMAP (0.697). In this way, the FFP-CMAP showed high inter-rater reproducibility because its shape was not much influenced by the electrode position. During 1-y follow-up, decline of CMAP, FFP, and MUNE showed significant correlations with the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R). DiscussionThe FFP-CMAP shows promise as a reliable marker for ALS.
- 22 April 2023
- Published by Wiley in Muscle & Nerve
- Vol. 68 (3) , 257-263
Far‐field potential of the compound muscle action potential as a reliable marker in amyotrophic lateral sclerosis
Introduction/AimsReliable neurophysiological markers in amyotrophic lateral sclerosis (ALS) are of great interest. The compound muscle action potential (CMAP) amplitude has been a conventional marker, although it is greatly influenced by the electrode position. We propose the far-field potential of the CMAP (FFP-CMAP) as a new neurophysiological marker in ALS. MethodsPatients with ALS and age-matched healthy controls were enrolled. We used a proximal reference (pref) in addition to the conventional distal reference (dref). Routine CMAP was recorded from the belly-dref lead and FFP-CMAP from the dref-pref lead for the ulnar and tibial nerves. Multiple point stimulation motor unit number estimation (MUNE) was also examined in the ulnar nerve. Inter-rater reproducibility was evaluated by two examiners, and some patients were followed up every 3 mo for 1 y. ResultsWe tested 17 patients with ALS and 10 controls. The amplitudes of routine CMAP and FFP-CMAP in the ulnar and tibial nerves, and hypothenar MUNE value in the ulnar nerve were significantly decreased in ALS compared to controls. Ulnar FFP-CMAP achieved the highest inter-rater intraclass correlation coefficient (ICC) value (0.942) when compared with routine CMAP (0.880) and MUNE (0.839). The tibial FFP-CMAP had a higher ICC value (0.986) than the routine CMAP (0.697). In this way, the FFP-CMAP showed high inter-rater reproducibility because its shape was not much influenced by the electrode position. During 1-y follow-up, decline of CMAP, FFP, and MUNE showed significant correlations with the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R). DiscussionThe FFP-CMAP shows promise as a reliable marker for ALS.
- 1 July 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (7) , 1496-1498
Peripheral nerve dysfunction in a patient with thyrotoxic periodic paralysis: Evidence from an axonal prolonged exercise test
- 1 July 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (7) , 1496-1498
Peripheral nerve dysfunction in a patient with thyrotoxic periodic paralysis: Evidence from an axonal prolonged exercise test
- 27 March 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (3) , 252-254
Recurrent cerebellar infarction due to vertebral artery dissection in an athetotic patient
A 42‐year‐old man with longstanding athetotic‐type cerebral palsy and history of cervical spine fusion surgery was affected by multiple episodes of vertebral artery dissections, resulting in bilateral cerebellar infarction. Continuous involuntary movements noted in the upper limbs and neck, as well as a limited cervical range of motion due to the operation might have precipitated the dissecting events.
- 27 March 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (3) , 252-254
Recurrent cerebellar infarction due to vertebral artery dissection in an athetotic patient
A 42‐year‐old man with longstanding athetotic‐type cerebral palsy and history of cervical spine fusion surgery was affected by multiple episodes of vertebral artery dissections, resulting in bilateral cerebellar infarction. Continuous involuntary movements noted in the upper limbs and neck, as well as a limited cervical range of motion due to the operation might have precipitated the dissecting events.
- 13 December 2020
- Published by Wiley in Muscle & Nerve
- Vol. 63 (3) , 365-370
Diagnostic usefulness of denervation edema in the multifidus muscles using 3‐Tesla magnetic resonance imaging in cervical radiculopathy
Background: Diagnosing cervical radiculopathy (CR) can be difficult because of symptomatic overlap with peripheral neuropathies. In this retrospective observational study, we aimed to determine whether short‐tau inversion recovery (STIR) magnetic resonance imaging (MRI) sequences are useful for detecting signs of denervation in the multifidus muscles in patients with CR.Methods: We analyzed the data of 18 patients with CR who developed arm weakness within 1 year. We also included 10 patients with sensorimotor symptoms involving the upper extremities who did not have intervertebral foraminal stenosis on MRI as controls. For each patient with CR, the signal intensity (SI) of the affected multifidus muscles was measured and compared to that on the contralateral side (signal intensity ratio: SIR).Results: Control patients without CR did not exhibit STIR signal abnormalities in the multifidus muscles. Most of the 18 patients with CR were male (83.3%), and the mean age was 59.4 years. Thirteen of 18 CR patients (72.2%) were determined to have STIR signal abnormalities by a radiologist. The mean SIR in the 13 patients with increased SI was significantly higher than that in the five patients without signal abnormalities (1.23 vs 0.97, P = .004), supporting the radiologist's diagnosis. The distribution of signal abnormalities closely followed those identified via clinical and electrophysiological tests, especially severe weakness (P = .044).Conclusions: Denervation edema of the multifidus muscles can be detected in CR and correlates with clinical/electrophysiological tests and weakness severity, which may aid in CR diagnostics.
- 13 December 2020
- Published by Wiley in Muscle & Nerve
- Vol. 63 (3) , 365-370
Diagnostic usefulness of denervation edema in the multifidus muscles using 3‐Tesla magnetic resonance imaging in cervical radiculopathy
Background: Diagnosing cervical radiculopathy (CR) can be difficult because of symptomatic overlap with peripheral neuropathies. In this retrospective observational study, we aimed to determine whether short‐tau inversion recovery (STIR) magnetic resonance imaging (MRI) sequences are useful for detecting signs of denervation in the multifidus muscles in patients with CR.Methods: We analyzed the data of 18 patients with CR who developed arm weakness within 1 year. We also included 10 patients with sensorimotor symptoms involving the upper extremities who did not have intervertebral foraminal stenosis on MRI as controls. For each patient with CR, the signal intensity (SI) of the affected multifidus muscles was measured and compared to that on the contralateral side (signal intensity ratio: SIR).Results: Control patients without CR did not exhibit STIR signal abnormalities in the multifidus muscles. Most of the 18 patients with CR were male (83.3%), and the mean age was 59.4 years. Thirteen of 18 CR patients (72.2%) were determined to have STIR signal abnormalities by a radiologist. The mean SIR in the 13 patients with increased SI was significantly higher than that in the five patients without signal abnormalities (1.23 vs 0.97, P = .004), supporting the radiologist's diagnosis. The distribution of signal abnormalities closely followed those identified via clinical and electrophysiological tests, especially severe weakness (P = .044).Conclusions: Denervation edema of the multifidus muscles can be detected in CR and correlates with clinical/electrophysiological tests and weakness severity, which may aid in CR diagnostics.
- 13 October 2020
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 31 (4) , 849-855
Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren’s syndrome
We evaluated usefulness of peripheral nerve ultrasound (US) in detecting abnormality in painful sensory neuropathy (PSN) associated with primary Sjögren's syndrome (pSS), and associations among various clinical factors, US findings, and intraepidermal nerve fiber density (IENFD). We conducted a retrospective, single-center, observational study of patients with pSS-PSN. US image was obtained to measure cross sectional area (CSA) of peripheral nerves and compared with matched pSS control. We included 11 patients with pSS-PSN (10 women; age 70.5 ± 5.66) and 17 pSS controls (15 women; age 62.5 ± 16.7). Sural nerve CSA were significantly increased in pSS-PSN group (3.48 ± 1.0 mm2 vs 2.05 ± 0.65 mm2, p = .001). US of sural nerve showed the area under the ROC curve of 0.872 (95% CI, 0.732 - 1). Sural nerve CSA and IENFD of lower leg showed positive correlation. Compared with pSS-PSN patients with abnormal IENFD, those with normal IENFD showed significantly larger sural nerve CSA, and trends toward less systemic disease activity and small fiber impairment with sparing of large fibers. US was useful in discriminating pSS patients with PSN from those without. Additionally, US may disclose distinct subsets of pSS-PSN with different clinical findings and IENFD.
- 13 October 2020
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 31 (4) , 849-855
Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren’s syndrome
We evaluated usefulness of peripheral nerve ultrasound (US) in detecting abnormality in painful sensory neuropathy (PSN) associated with primary Sjögren's syndrome (pSS), and associations among various clinical factors, US findings, and intraepidermal nerve fiber density (IENFD). We conducted a retrospective, single-center, observational study of patients with pSS-PSN. US image was obtained to measure cross sectional area (CSA) of peripheral nerves and compared with matched pSS control. We included 11 patients with pSS-PSN (10 women; age 70.5 ± 5.66) and 17 pSS controls (15 women; age 62.5 ± 16.7). Sural nerve CSA were significantly increased in pSS-PSN group (3.48 ± 1.0 mm2 vs 2.05 ± 0.65 mm2, p = .001). US of sural nerve showed the area under the ROC curve of 0.872 (95% CI, 0.732 - 1). Sural nerve CSA and IENFD of lower leg showed positive correlation. Compared with pSS-PSN patients with abnormal IENFD, those with normal IENFD showed significantly larger sural nerve CSA, and trends toward less systemic disease activity and small fiber impairment with sparing of large fibers. US was useful in discriminating pSS patients with PSN from those without. Additionally, US may disclose distinct subsets of pSS-PSN with different clinical findings and IENFD.
- 1 October 2019
- Published by Elsevier in Clinical Neurophysiology
- Vol. 130 (10) , 1997
Reply to “Artificial intelligence in the field of electrodiagnosis – A new threat or heralding a new era in electromyography?”
- 1 October 2019
- Published by Elsevier in Clinical Neurophysiology
- Vol. 130 (10) , 1997
Reply to “Artificial intelligence in the field of electrodiagnosis – A new threat or heralding a new era in electromyography?”
- Open Access
- 18 July 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-8
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report
The coexistence of distinct neurodegenerative diseases in single cases has recently attracted greater attention. The phenotypic co-occurrence of progressive supranuclear palsy (PSP) and amyotrophic lateral sclerosis (ALS) has been documented in several cases. That said, the clinicopathological comorbidity of these two diseases has not been demonstrated. A 77-year-old man presented with gait disturbance for 2 years, consistent with PSP with progressive gait freezing. At 79 years old, he developed muscle weakness compatible with ALS. The disease duration was 5 years after the onset of PSP and 5 months after the onset of ALS. Neuropathological findings demonstrated the coexistence of PSP and ALS. Immunohistochemical examination confirmed 4-repeat tauopathy, including globose-type neurofibrillary tangles, tufted astrocytes, and oligodendroglial coiled bodies as well as TAR DNA-binding protein 43 kDa pathology in association with upper and lower motor neuron degeneration. Immunoblotting showed hyperphosphorylated full-length 4-repeat tau bands (64 and 68 kDa) and C-terminal fragments (33 kDa), supporting the diagnosis of PSP and excluding other parkinsonian disorders, such as corticobasal degeneration. Genetic studies showed no abnormalities in genes currently known to be related to ALS or PSP. Our case demonstrates the clinicopathological comorbidity of PSP and ALS in a sporadic patient. The possibility of multiple proteinopathies should be considered when distinct symptoms develop during the disease course.
- 18 July 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-8
Open AccessCo-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report
The coexistence of distinct neurodegenerative diseases in single cases has recently attracted greater attention. The phenotypic co-occurrence of progressive supranuclear palsy (PSP) and amyotrophic lateral sclerosis (ALS) has been documented in several cases. That said, the clinicopathological comorbidity of these two diseases has not been demonstrated. A 77-year-old man presented with gait disturbance for 2 years, consistent with PSP with progressive gait freezing. At 79 years old, he developed muscle weakness compatible with ALS. The disease duration was 5 years after the onset of PSP and 5 months after the onset of ALS. Neuropathological findings demonstrated the coexistence of PSP and ALS. Immunohistochemical examination confirmed 4-repeat tauopathy, including globose-type neurofibrillary tangles, tufted astrocytes, and oligodendroglial coiled bodies as well as TAR DNA-binding protein 43 kDa pathology in association with upper and lower motor neuron degeneration. Immunoblotting showed hyperphosphorylated full-length 4-repeat tau bands (64 and 68 kDa) and C-terminal fragments (33 kDa), supporting the diagnosis of PSP and excluding other parkinsonian disorders, such as corticobasal degeneration. Genetic studies showed no abnormalities in genes currently known to be related to ALS or PSP. Our case demonstrates the clinicopathological comorbidity of PSP and ALS in a sporadic patient. The possibility of multiple proteinopathies should be considered when distinct symptoms develop during the disease course.
- 17 May 2019
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 7 (5) , 267-275
Deep learning for identification of fasciculation from muscle ultrasound images
Background: Detection of fasciculation plays a significant role in the early diagnosis of amyotrophic lateral sclerosis (ALS). Although ultrasound (US) has been reported to be superior to needle electromyography (EMG) and visual inspection in terms of detection rates, other similar movements could lower the reliability of the result. Artificial intelligence, such as deep learning, promises to enhance the classification of visual data.Aim: To classify fasciculation and its mimics by deep learning.Methods: Using an 11‐MHz linear‐array transducer, muscle US was recorded from the biceps brachii and tibialis anterior muscles. Fasciculation for patients with ALS, and movements of voluntary muscles or the recording probe of healthy individuals were recorded. Background subtraction was performed to obtain binary images to infer movements. Deep learning was performed using five different networks with and without pre‐trained weights.Results: Three groups of images were divided into training, validation, and test (fasciculation: N = 1473; voluntary movement: N = 861; probe movement: N = 1626). The accuracy of detection with pre‐trained weights (fine‐tuning) ranged from 0.959 to 1.0. The best accuracy was obtained by VGG16/19 convolutional neural networks and the ResNet‐152 network. Accuracy of prediction was considerably lower without the pre‐trained weights. The mean white pixels (inferring movements) were lower in fasciculation than in the voluntary and probe movement groups; however, the non‐fasciculation groups showed similar pixel counts (P = 0.95).Conclusions: US accurately distinguished between fasciculation and its mimics by deep learning. Pixel counting could be a reliable quantitative method to detect fasciculation.
- 17 May 2019
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 7 (5) , 267-275
Deep learning for identification of fasciculation from muscle ultrasound images
Background: Detection of fasciculation plays a significant role in the early diagnosis of amyotrophic lateral sclerosis (ALS). Although ultrasound (US) has been reported to be superior to needle electromyography (EMG) and visual inspection in terms of detection rates, other similar movements could lower the reliability of the result. Artificial intelligence, such as deep learning, promises to enhance the classification of visual data.Aim: To classify fasciculation and its mimics by deep learning.Methods: Using an 11‐MHz linear‐array transducer, muscle US was recorded from the biceps brachii and tibialis anterior muscles. Fasciculation for patients with ALS, and movements of voluntary muscles or the recording probe of healthy individuals were recorded. Background subtraction was performed to obtain binary images to infer movements. Deep learning was performed using five different networks with and without pre‐trained weights.Results: Three groups of images were divided into training, validation, and test (fasciculation: N = 1473; voluntary movement: N = 861; probe movement: N = 1626). The accuracy of detection with pre‐trained weights (fine‐tuning) ranged from 0.959 to 1.0. The best accuracy was obtained by VGG16/19 convolutional neural networks and the ResNet‐152 network. Accuracy of prediction was considerably lower without the pre‐trained weights. The mean white pixels (inferring movements) were lower in fasciculation than in the voluntary and probe movement groups; however, the non‐fasciculation groups showed similar pixel counts (P = 0.95).Conclusions: US accurately distinguished between fasciculation and its mimics by deep learning. Pixel counting could be a reliable quantitative method to detect fasciculation.